SWP
TMO icon

ShoreHaven Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

ShoreHaven Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60
Closed -$27K – 231
2021
Q1 		$27K Hold
60
– – 0.01% 158
2020
Q4 		$28K Buy
+60
New +$28.1K 0.02% 139

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ShoreHaven Wealth Partners's TMO Position: Q2 2021 in Review

ShoreHaven Wealth Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 60 shares — an estimated $27K sold.

ShoreHaven Wealth Partners first reported a position in TMO in Q4 2020 and held it in 2 quarters. The position peaked at $28K in Q4 2020. 2,077 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • ShoreHaven Wealth Partners reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • ShoreHaven Wealth Partners sold 60 Thermo Fisher Scientific shares in Q2 2021, an estimated $27K.
  • ShoreHaven Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 2 quarters.
  • ShoreHaven Wealth Partners's Thermo Fisher Scientific position peaked at $28K in Q4 2020.
  • 2,077 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on ShoreHaven Wealth Partners's 13F filing for Q2 2021, filed 16 Aug 2021.